Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKAPE.L Regulatory News (KAPE)

  • There is currently no data for KAPE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8 (OPD) Kape Technologies plc

27 Feb 2023 11:56

RNS Number : 1720R
Kape Technologies PLC
27 February 2023
 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Kape Technologies plc

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Kape Technologies plc

(d) Is the discloser the offeror or the offeree?

OFFEREE

(e) Date position held:

The latest practicable date prior to the disclosure

27 February 2023

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

Ordinary shares of USD0.0001

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

Nil

-

Nil

-

(2) Cash-settled derivatives:

 

Nil

-

Nil

-

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

-

Nil

-

 

TOTAL:

Nil

-

Nil

-

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

None

Details, including nature of the rights concerned and relevant percentages:

N/A

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

 

a) Holdings of ordinary shares by the independent directors of Kape Technologies plc (the "Company") and their close relatives:

 

Name

Number of Ordinary Shares held

% of total issued share capital

Ido Erlichman

550,000

0.12%

Oded Baskind

15,100

0.00%

Daniel Pomerantz*

25,375,642

5.92%

Don Elgie

122,031

0.02%

Martin Blair

57,750

0.01%

David Cotterell

202,544

0.04%

 

* The holdings, and options, of Daniel Pomerantz are disclosed in RNS number 9083P, released on 14 February 2023.

 

Name

Number of Ordinary Shares subject to Jointly Owned Equity Awards ("JOE Awards") **

% of total issued share capital carrying voting rights

Ido Erlichman

3,400,000

N/A

Oded Baskind

600,000

N/A

 

*\* The Company's employee benefit trust ("EBT"), of which Intertrust Employee Benefit Trustee Limited (the "Trustee") is trustee, holds the 4,000,000 ordinary shares in the Company in respect of the above JOE Awards. The JOE Awards are subject to certain performance metrics. Ordinary shares held by the EBT, under the rules of the EBT, are not voted. 

 

b) The directors of the Company have the following rights to subscribe for the following relevant Kape Technologies plc securities:

 

Name

Date of grant

Vesting period

Exercise price (p)

No. of options outstanding

Oded Baskind

21/05/2019

25% vest on the first anniversary of the date of grant and the remainder in quarterly instalments thereafter with the final instalment vesting on the 4th anniversary of the date of grant

0.85

18,750

Oded Baskind

22/03/2021

25% vest on the first anniversary of the date of grant and the remainder in quarterly instalments thereafter with the final instalment vesting on the 4th anniversary of the date of grant

2.15

250,000

Daniel Pomerantz

15/09/2022

412,000 vest on 14 March 2023 and the remainder in quarterly instalments thereafter with the final instalment vesting on 15 December 2023, in each case subject to certain performance metrics.

Nil cost

721,000

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

27 February 2023

Contact name:

Oded Baskind, Chief Financial Officer

Telephone number:

via Vigo Consulting ; +44 (0)20 7390 0237

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FEEUBVAROUUUUAR
Date   Source Headline
22nd Mar 20227:00 amRNSFinal Results
18th Mar 20224:34 pmRNSBlock listing Interim Review
15th Mar 20227:00 amRNSAnalyst and Investor Presentations
19th Jan 202212:30 pmRNSHolding(s) in Company
19th Jan 202210:00 amRNSDirector/PDMR Shareholding
18th Jan 20227:01 amRNSDirectorate Changes
18th Jan 20227:00 amRNSTrading Update, Presentation & Notice of Results
5th Jan 20227:00 amRNSIssue of Equity
20th Dec 20211:00 pmRNSHolding(s) in Company
20th Dec 20217:00 amRNSHolding(s) in Company
20th Dec 20217:00 amRNSHolding(s) in Company
15th Dec 20213:21 pmRNSCompletion of acquisition & business update
12th Nov 20213:10 pmRNSHolding(s) in Company
25th Oct 20217:00 amRNSHolding(s) in Company
4th Oct 20217:00 amRNSDirector/PDMR Dealings & Exercise of Options
1st Oct 20211:01 pmRNSResults of General Meeting and Total Voting Rights
27th Sep 20217:00 amRNSHolding(s) in Company
21st Sep 20217:00 amRNSHalf-year Results
16th Sep 202112:12 pmRNSSecond Price Monitoring Extn
16th Sep 202112:11 pmRNSPrice Monitoring Extension
16th Sep 20217:00 amRNSNotice of Results & Analyst/Investor Presentation
15th Sep 20212:00 pmRNSPosting of Shareholder circular and notice of GM
14th Sep 20219:05 amRNSSecond Price Monitoring Extn
14th Sep 20219:00 amRNSPrice Monitoring Extension
14th Sep 20217:00 amRNSResult of Placing & Retail Offer & Notice of GM
13th Sep 20214:41 pmRNSRetail Offer by PrimaryBid
13th Sep 20214:40 pmRNS$936m acquisition of ExpressVPN & $354m Placing
13th Sep 20217:00 amRNSBlocklisting Return & Total Voting Rights
20th Jul 20217:00 amRNSTrading Update
15th Jul 20217:00 amRNSPIA introduces a new way of VPN subscription
28th May 20217:00 amRNSNew Bank Facility
20th May 20212:18 pmRNSResults of AGM
20th May 20217:00 amRNSAGM Statement
6th May 202111:36 amRNSTotal Voting Rights
29th Apr 20217:00 amRNSExercise of Options and Director/PDMR Shareholding
26th Apr 20217:00 amRNSPosting of Annual Report and Notice of AGM
31st Mar 20217:00 amRNSPDMR Dealings
26th Mar 20211:49 pmRNSResult of General Meeting and Total Voting Rights
19th Mar 20217:00 amRNSInvestor Presentation
17th Mar 202112:13 pmRNSBlocklisting Return
17th Mar 20217:00 amRNSFinal Results
10th Mar 20217:00 amRNSNotice of General Meeting
8th Mar 202111:05 amRNSSecond Price Monitoring Extn
8th Mar 202111:00 amRNSPrice Monitoring Extension
8th Mar 20217:00 amRNSAcquisition of Webselenese
19th Jan 20217:00 amRNSTrading Update & Notice of Results
11th Jan 20217:00 amRNSAppointment of Joint Broker
6th Jan 20217:00 amRNSAppointment of Non-executive Director
5th Jan 202111:54 amRNSTotal Voting Rights
30th Dec 20202:45 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.